ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
16/04/2025
Voltar para busca
Dado oficial do USPTO
AFYX THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AFYX THERAPEUTICS
ST13
US500000088279875Classe
5, 42, 44
Pedido
88279875
Registro
5987801
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
06/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
28/01/2019
Data de registro
18/02/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/02/2020
Última transação
06/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
65
Localização do titular
H�RSHOLM, DK
Examinador
WILKE, JOHN
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
AFYX DEVELOPMENT A/S
AFYX THERAPEUTICS A/S
Dermtreat A/S
Representantes
Carolyn M. Gouges d'Agincourt Verrill Dana LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticals for treatment of mucosal diseases; pharmaceutical preparations and substances for treatment of mucosal diseases; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for treating mucous membrane disorders; pharmaceutical preparationsmuco adhesive patches for efficient and uniform drug release; medicine for treatment of mucosal diseases; medical preparations and articles for treatment of mucosal diseases; medical preparations and articlesmucous membrane- and skin- adhesive patches for coverage of lesions and/or efficient and uniform drug delivery; patches for treatment of mucosal diseases; adhesive patches for medical purposesnamely for treatment of mucosal diseases; skin patches for the transdermal delivery of pharmaceuticals for use in the treatment of mucosal diseases; mucous membrane patches for the transdermal delivery of pharmaceuticals for use in the treatment of mucosal diseases; transdermal patches for use in the treatment of mucosal diseases; transdermal patches for medical treatment for use in the treatment of mucosal diseases; transmucosal patches for medical treatment of mucosal diseases; dressingsmedical; adhesive dressings; dressings for wounds; bandagesmedical; adhesive bandages; bandages for skin wounds; bandages for mucous membrane wounds; mucosal surface delivery of pharmaceuticals for use in the treatment of mucosal diseases
Classe 42
Scientificmedical and pharmaceutical research and development services; research and development of pharmaceutical preparations; research and development of pharmaceutical preparations for treating skin disorders; research and development of pharmaceutical preparations for treating mucous membrane disorders; research and development of pharmaceutical preparationsmuco adhesive patches for efficient and uniform drug release; research and development of medicines; research and development of medical preparations and articles; research and development of medical preparations and articlesmucous membrane- and skin- adhesive patches for coverage of lesions and/or efficient and uniform drug delivery; medical research and analysis services; biological research; clinical research in the field of treatment of mucosal diseases; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals
Classe 44
Medical services; medical treatment services; medical screening; medical monitoringtestinginspection and analysis services; medical services relating to the diagnosis and treatment of skin disorders; medical services relating to the diagnosis and treatment of mucous membrane disorders; pharmaceutical compounding services; pharmaceutical advisory services; dermatological services for treating skin conditions; dermatological services for treating mucous membrane conditions; laboratory analysis services relating to the diagnosis and treatment of skin disorders; medical laboratory analysis services provided by medical laboratories relating to the diagnosis and treatment of mucous membrane disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/03/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
25/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/03/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
25/03/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
25/03/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
06/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/12/2024
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
06/12/2024
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
06/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
18/02/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
15/01/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
15/01/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
26/11/2019
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
26/11/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/10/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/10/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2019
PUBO
PUBLISHED FOR OPPOSITION
06/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/07/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/07/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
28/06/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
21/06/2019
ALIE
ASSIGNED TO LIE
19/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/06/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/04/2019
GNRT
NON-FINAL ACTION E-MAILED
09/04/2019
CNRT
NON-FINAL ACTION WRITTEN
09/04/2019
DOCK
ASSIGNED TO EXAMINER
09/04/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/02/2019
NWAP
NEW APPLICATION ENTERED
31/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AFYX THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.